This is a preview of subscription content, log in via an institution to check access.
Reference
Romero RM, et al. Expanded access of trifluridine/tipiracil (tas-102) in metastastic colorrectal cancer. Experience in a third level hospital. International Journal of Clinical Pharmacy 40: 308 abstr. PT047, No. 1, Feb 2018. Available from: URL: http://doi.org/10.1007/s11096-017-0565-9 [abstract] - Spain
Rights and permissions
About this article
Cite this article
Tipiracil/trifluridine. Reactions Weekly 1697, 374 (2018). https://doi.org/10.1007/s40278-018-44930-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44930-9